{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T15:48:29Z","timestamp":1780588109977,"version":"3.54.1"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>The presence of the A118G single nucleotide polymorphism in the <jats:italic toggle=\"yes\">OPRM1<\/jats:italic> gene as well as noxious stimulation might affect the requirements of remifentanil for patients undergoing ultrasonographic endoscopy under sedation-analgesia with propofol and remifentanil. Bispectral index (BIS) was used as a surrogate measure of effect.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A total of 207 patients were screened for A118G and randomly received different combinations of propofol and remifentanil, changed depending on the nausea response to endoscopy tube introduction. Nonlinear mixed effects modelling was used to establish the relation between propofol and remifentanil with respect to BIS and to investigate the influence of A118G or noxious stimulation. The value of k<jats:sub>e0<\/jats:sub> for propofol and remifentanil was estimated to avoid the hysteresis between predicted effect site concentration (Ce) and BIS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Data from 176 patients were analysed. Eleven were recessive homozygous for A118G (OPRM = 1). A total of 165 patients were either dominant homozygous or heterozygous and considered normal (OPRM = 0). The estimated values of k<jats:sub>e0<\/jats:sub> for propofol and remifentanil were 0.122 and 0.148min<jats:sup>\u22121<\/jats:sup>. Propofol and remifentanil were synergistic with respect to the BIS (\u03b1 = 1.85). EC<jats:sub>50<\/jats:sub> estimate for propofol was 3.86 \u00b5g\/ml and for remifentanil 19.6 ng\/ml in normal patients and 326ng\/ml in OPRM = 1 patients. BIS increases around 4% for the same effect site concentrations with noxious stimulation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Predicted effect site concentration of remifentanil ranging 1\u20135ng\/ml synergistically potentiates the effects of propofol on the BIS but has no effect in A118G patients. Noxious stimulation increases BIS values by 4% at the same concentrations of propofol and remifentanil.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aln.0b013e31828e1544","type":"journal-article","created":{"date-parts":[[2013,3,22]],"date-time":"2013-03-22T22:03:19Z","timestamp":1363989799000},"page":"1395-1407","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":24,"title":["Modeling the Influence of the A118G Polymorphism in the OPRM1 Gene and of Noxious Stimulation on the Synergistic Relation between Propofol and Remifentanil"],"prefix":"10.1097","volume":"118","author":[{"given":"Xavier","family":"Borrat","sequence":"first","affiliation":[{"name":"Staff Anesthesiologist"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I\u00f1aki F.","family":"Troc\u00f3niz","sequence":"additional","affiliation":[{"name":"Professor, Department of Pharmacy and Pharmaceutical Technology, School of Pharmacy, Universidad de Navarra, Pamplona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 F.","family":"Valencia","sequence":"additional","affiliation":[{"name":"Research Associate in Bioengineering, Systems Pharmacology Effect Control and Modeling Research Group of the Department of Anesthesia, Hospital CLINIC de Barcelona, Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Rivadulla","sequence":"additional","affiliation":[{"name":"Staff CRNA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriol","family":"Sendino","sequence":"additional","affiliation":[{"name":"Staff Gastroenterologist"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Llach","sequence":"additional","affiliation":[{"name":"Associate Professor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenifer","family":"Mu\u00f1oz","sequence":"additional","affiliation":[{"name":"Research Technician"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergi","family":"Castellv\u00ed-Bel","sequence":"additional","affiliation":[{"name":"Research Associate"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Jospin","sequence":"additional","affiliation":[{"name":"Research Associate, Centre for Biomedical Engineering Research, Universitat Polit\u00e8cnica de Catalunya, CIBER of Bioengineering, Biomaterials and Nanomedicine, Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik W.","family":"Jensen","sequence":"additional","affiliation":[{"name":"Research Associate, Centre for Biomedical Engineering Research, Universitat Polit\u00e8cnica de Catalunya, CIBER of Bioengineering, Biomaterials and Nanomedicine, Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Castells","sequence":"additional","affiliation":[{"name":"Professor and Head, Gastroenterology Department, Hospital CLINIC, CIBERehd, The August Pi i Sunyer Biomedical Research Institute, University of Barcelona, Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro L.","family":"Gamb\u00fas","sequence":"additional","affiliation":[{"name":"Visiting Associate Professor, Department of Anesthesia and Perioperative Care, University of California, San Francisco, San Francisco, California, and Systems Pharmacology Effect Control and Modeling Research Group of the Department of Anesthesia, Hospital CLINIC de Barcelona."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20241219","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1213\/ANE.0b013e3182025a70","article-title":"Modeling the effect of propofol and remifentanil combinations for sedation-analgesia in endoscopic procedures using an Adaptive Neuro Fuzzy Inference System (ANFIS).","volume":"112","year":"2011","journal-title":"Anesth Analg"},{"key":"R2-20241219","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1097\/00000542-200406000-00006","article-title":"Pharmacodynamic interaction between propofol and remifentanil regarding hypnosis, tolerance of laryngoscopy, bispectral index, and electroencephalographic approximate entropy.","volume":"100","year":"2004","journal-title":"Anesthesiology"},{"key":"R3-20241219","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/978-3-540-74806-9_19","article-title":"Defining depth of anesthesia.","volume":"182","year":"2008","journal-title":"Handb Exp Pharmacol"},{"key":"R4-20241219","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1097\/00000542-199906000-00003","article-title":"The influence of age on propofol pharmacodynamics.","volume":"90","year":"1999","journal-title":"Anesthesiology"},{"key":"R5-20241219","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00000542-199701000-00004","article-title":"Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development.","volume":"86","year":"1997","journal-title":"Anesthesiology"},{"key":"R6-20241219","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/clpt.2012.131","article-title":"Individualized dosing with anesthetic agents.","volume":"92","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"R7-20241219","doi-asserted-by":"crossref","first-page":"9608","DOI":"10.1073\/pnas.95.16.9608","article-title":"Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: Possible implications for opiate addiction.","volume":"95","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"R8-20241219","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/00000542-200608000-00016","article-title":"Human opioid receptor A118G polymorphism affects intravenous patient-controlled analgesia morphine consumption after total abdominal hysterectomy.","volume":"105","year":"2006","journal-title":"Anesthesiology"},{"key":"R9-20241219","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.molmed.2004.12.006","article-title":"Are mu-opioid receptor polymorphisms important for clinical opioid therapy?","volume":"11","year":"2005","journal-title":"Trends Mol Med"},{"key":"R10-20241219","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/j.1399-6576.2005.00772.x","article-title":"Genetic variability and clinical efficacy of morphine.","volume":"49","year":"2005","journal-title":"Acta Anaesthesiol Scand"},{"key":"R11-20241219","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1111\/j.1399-6576.2004.00517.x","article-title":"The 118 A > G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease.","volume":"48","year":"2004","journal-title":"Acta Anaesthesiol Scand"},{"key":"R12-20241219","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1097\/00000542-200210000-00011","article-title":"Does the A118G polymorphism at the mu-opioid receptor gene protect against morphine-6-glucuronide toxicity?","volume":"97","year":"2002","journal-title":"Anesthesiology"},{"key":"R13-20241219","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/00000542-200401000-00021","article-title":"Pharmacokinetic-pharmacodynamic modeling of morphine-6-glucuronide-induced analgesia in healthy volunteers: Absence of sex differences.","volume":"100","year":"2004","journal-title":"Anesthesiology"},{"key":"R14-20241219","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1067\/mcp.2003.5","article-title":"Analgesic effects of morphine and morphine-6-glucuronide in a transcutaneous electrical pain model in healthy volunteers.","volume":"73","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"R15-20241219","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1476-5381.2010.01074.x","article-title":"Pharmacogenetics of new analgesics.","volume":"163","year":"2011","journal-title":"Br J Pharmacol"},{"key":"R16-20241219","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1097\/00000542-199805000-00006","article-title":"The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers.","volume":"88","year":"1998","journal-title":"Anesthesiology"},{"key":"R17-20241219","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0149-7634(05)80090-9","article-title":"Staircase bioassay: The up-and-down method.","volume":"15","year":"1991","journal-title":"Neurosci Biobehav Rev"},{"key":"R18-20241219","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/01.anes.0000267514.42592.2a","article-title":"Advances in and limitations of up-and-down methodology: A pr\u00e9cis of clinical use, study design, and dose estimation in anesthesia research.","volume":"107","year":"2007","journal-title":"Anesthesiology"},{"key":"R20-20241219","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1007\/s11095-007-9361-x","article-title":"Conditional weighted residuals (CWRES): A model diagnostic for the FOCE method.","volume":"24","year":"2007","journal-title":"Pharm Res"},{"key":"R21-20241219","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1109\/TAC.1974.1100705","article-title":"A new look at the statistical model identification.","volume":"19","year":"1974","journal-title":"IEEE Trans Autom Control"},{"key":"R22-20241219","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.cmpb.2005.04.005","article-title":"PsN-Toolkit\u2014a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM.","volume":"79","year":"2005","journal-title":"Comput Methods Programs Biomed"},{"key":"R23-20241219","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/cpt1979253358","article-title":"Simultaneous modeling of pharmacokinetics and pharmacodynamics: Application to d-tubocurarine.","volume":"25","year":"1979","journal-title":"Clin Pharmacol Ther"},{"key":"R24-20241219","first-page":"331","article-title":"The search for synergy: A critical review from a response surface perspective.","volume":"47","year":"1995","journal-title":"Pharmacol Rev"},{"key":"R25-20241219","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1097\/00000542-200406000-00007","article-title":"A response surface analysis of propofol\u2013remifentanil pharmacodynamic interaction in volunteers.","volume":"100","year":"2004","journal-title":"Anesthesiology"},{"key":"R26-20241219","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1097\/00000542-200006000-00017","article-title":"Response surface model for anesthetic drug interactions.","volume":"92","year":"2000","journal-title":"Anesthesiology"},{"key":"R27-20241219","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10928-010-9157-1","article-title":"A two-compartment effect site model describes the bispectral index after different rates of propofol infusion.","volume":"37","year":"2010","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"R28-20241219","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1213\/01.ane.0000231634.20341.88","article-title":"A genetic association study of the functional A118G polymorphism of the human mu-opioid receptor gene in patients with acute and chronic pain.","volume":"103","year":"2006","journal-title":"Anesth Analg"},{"key":"R29-20241219","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/00000542-200603000-00016","article-title":"Time delay of index calculation: Analysis of cerebral state, bispectral, and narcotrend indices.","volume":"104","year":"2006","journal-title":"Anesthesiology"},{"key":"R30-20241219","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/bja\/aeq028","article-title":"Study of the time course of the clinical effect of propofol compared with the time course of the predicted effect-site concentration: Performance of three pharmacokinetic-dynamic models.","volume":"104","year":"2010","journal-title":"Br J Anaesth"},{"key":"R31-20241219","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/bja\/aem408","article-title":"Pharmacodynamic modelling of the bispectral index response to propofol-based anaesthesia during general surgery in children.","volume":"100","year":"2008","journal-title":"Br J Anaesth"},{"key":"R32-20241219","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1097\/00000542-199906000-00004","article-title":"Comparison of the effect-site k(eO)s of propofol for blood pressure and EEG bispectral index in elderly and younger patients.","volume":"90","year":"1999","journal-title":"Anesthesiology"},{"key":"R33-20241219","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/ALN.0b013e31821a8d80","article-title":"An evaluation of using population pharmacokinetic models to estimate pharmacodynamic parameters for propofol and bispectral index in children.","volume":"115","year":"2011","journal-title":"Anesthesiology"},{"key":"R34-20241219","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/00000542-199901000-00014","article-title":"Targeting effect compartment or central compartment concentration of propofol: What predicts loss of consciousness?","volume":"90","year":"1999","journal-title":"Anesthesiology"},{"key":"R35-20241219","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/00000542-200302000-00008","article-title":"Response surface modeling of remifentanil-propofol interaction on cardiorespiratory control and bispectral index.","volume":"98","year":"2003","journal-title":"Anesthesiology"},{"key":"R36-20241219","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/00000542-200203000-00009","article-title":"The influence of remifentanil on the dynamic relationship between sevoflurane and surrogate anesthetic effect measures derived from the EEG.","volume":"96","year":"2002","journal-title":"Anesthesiology"},{"key":"R37-20241219","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/00000542-200303000-00008","article-title":"Correlation of approximate entropy, bispectral index, and spectral edge frequency 95 (SEF95) with clinical signs of \u201canesthetic depth\u201d during coadministration of propofol and remifentanil.","volume":"98","year":"2003","journal-title":"Anesthesiology"},{"key":"R38-20241219","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/00000542-200503000-00008","article-title":"Polymorphism of mu-opioid receptor gene (OPRM1:c.118A>G) does not protect against opioid-induced respiratory depression despite reduced analgesic response.","volume":"102","year":"2005","journal-title":"Anesthesiology"}],"container-title":["Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/pubs.asahq.org\/anesthesiology\/article-pdf\/118\/6\/1395\/260975\/20130600_0-00027.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/anesthesiology.pubs.asahq.org\/article.aspx?volume=118&page=1395","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T16:00:18Z","timestamp":1737561618000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/ALN.0b013e31828e1544"}},"subtitle":["Sedation and Analgesia in Endoscopic Procedures"],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/aln.0b013e31828e1544","relation":{},"ISSN":["0003-3022"],"issn-type":[{"value":"0003-3022","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}